Metraipolis › archive › dc_93ddac18212c
Clinical Applications of CDK4/6 Inhibitors in HR+/HER2, and Personalized Treatment Strategies: A Narrative Review — Europe PMC PMID:42220439
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42220439
- DOI
- 10.32604/or.2026.076300
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:29:36.039Z
- SHA-256 of the archived text
490e86572f5a3920f12f3a7ee611a922befc2f0480cf136eefd3a875c99d679f- Stable URL of this page
https://metraipolis.com/documento/dc_93ddac18212c
How to cite
Clinical Applications of CDK4/6 Inhibitors in HR+/HER2, and Personalized Treatment Strategies: A Narrative Review — Europe PMC PMID:42220439 — Europe PMC (en), https://europepmc.org/article/MED/42220439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93ddac18212c (Metraipolis archive dc_93ddac18212c, sha256 490e86572f5a3920f12f3a7ee611a922befc2f0480cf136eefd3a875c99d679f)
BibTeX
@misc{dc93ddac18212c,
title = {Clinical Applications of CDK4/6 Inhibitors in HR+/HER2, and Personalized Treatment Strategies: A Narrative Review — Europe PMC PMID:42220439},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42220439},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93ddac18212c; sha256 490e86572f5a3920f12f3a7ee611a922befc2f0480cf136eefd3a875c99d679f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220439. Agents can read the archived copy with the MCP tool read_document.